Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SHEL vs GSK✓SelectedUSD · GSKSHEL vs GSK performance historyLatest closeAs of-0.35%11/19
Stock and ETF performance explorer

SHEL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+193.4%
GSK return
+97.7%
Excess return
+95.7%
Maximum drawdown
-67.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.3%-1.6%+1.2%+0.2%
7D-3.9%-4.7%+0.9%-2.2%
30D-10.2%-4.7%-5.5%-8.8%
3M+2.1%-8.8%+10.9%+5.2%
6M+9.0%-4.6%+13.7%+9.9%
YTD+32.5%+1.0%+31.5%+28.9%
1Y+32.2%+6.9%+25.3%+25.5%
3Y+60.3%+52.5%+7.7%+23.9%
5Y+161.1%+40.3%+120.8%+105.9%
All+193.4%+97.7%+95.7%+97.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling